|
Market Closed -
Nasdaq
16:00:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 10.28 USD | -0.77% |
|
+4.79% | +14.73% |
| Market Cap | 610M 547M 503M 456M 852M 57.96B 868M 6B 2.41B 30.49B 2.29B 2.24B 96.16B | P/E 2026 * |
9.17x | P/E 2027 * | 11.5x |
|---|---|---|---|---|---|
| Enterprise Value | 610M 547M 503M 456M 852M 57.96B 868M 6B 2.41B 30.49B 2.29B 2.24B 96.16B | EV / Sales 2026 * |
3.98x | EV / Sales 2027 * | 3.44x |
| Free-Float |
96.14% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ZVRA | Delayed | |
CBOE
| ZVRA | Real-time | |
|
Deutsche Boerse AG
| 1GDA | Delayed | |
|
Tradegate
| 1GDA | Real-time | |
|
Börse Stuttgart
| 1GDA | Delayed | |
|
Boerse Muenchen
| 1GDA | Real-time |
Last Transcript: Zevra Therapeutics, Inc.
| 1 day | -0.77% | ||
| 1 week | +4.79% | ||
| 1 month | -6.29% | ||
| 3 months | +8.10% | ||
| 6 months | +1.08% | ||
| Current year | +14.73% |
| 1 week | 9.46 |  | 10.55 |
| 1 month | 9.46 | | 11.46 |
| Current year | 8.08 | | 15.04 |
| 1 year | 8.01 | | 15.04 |
| 3 years | 3.89 | | 15.04 |
| 5 years | 3.89 | | 15.04 |
| 10 years | 1.94 | | 134.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Neil McFarlane
CEO | Chief Executive Officer | 53 | 2023-10-09 |
Justin Renz
DFI | Director of Finance/CFO | 54 | 2026-03-08 |
Rahsaan Thompson
CMP | Compliance Officer | 55 | 2024-06-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Tamara Favorito
CHM | Chairman | 67 | 2023-05-07 |
Douglas Calder
BRD | Director/Board Member | 59 | 2023-04-24 |
Corey Watton
BRD | Director/Board Member | 56 | 2023-04-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/12/26 | Sell | Chief Executive Officer | -20,000 | 0.0337% | ||
| 8/14/26 | Sell | Compliance Officer | -42,666 | 0.0722% | ||
| 8/10/26 | Exercice | Director | 36,900 | 0.0624% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.77% | +4.79% | +0.98% | +129.46% | 610M | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | |
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | |
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | |
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | |
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | |
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | |
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | |
| Average | +1.80% | +5.79% | +42.02% | +89.05% | 426.25B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.50% | +100.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 153M 137M 126M 114M 214M 14.55B 218M 1.51B 605M 7.66B 575M 563M 24.15B | 178M 159M 146M 133M 248M 16.87B 253M 1.75B 701M 8.88B 667M 653M 27.99B |
| Net income | 68.14M 61.03M 56.14M 50.86M 95.08M 6.47B 96.86M 669M 269M 3.4B 256M 250M 10.73B | 55.27M 49.5M 45.53M 41.26M 77.12M 5.25B 78.56M 543M 218M 2.76B 207M 203M 8.71B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | US$10.28 | -0.77% | 642,042 |
| 26-10-29 | US$10.36 | +0.48% | 507,871 |
| 26-10-28 | US$10.31 | +2.54% | 976,142 |
| 26-10-27 | US$10.06 | +5.51% | 1,089,518 |
| 26-10-26 | US$9.530 | -2.85% | 722,197 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZVRA Stock
Select your edition
All financial news and data tailored to specific country editions
